Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfgang Galetzka

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Deutsches Arzteblatt International|August 6, 2024
One Question, Many Results—Why Epidemiological Studies Yield Heterogeneous Findings. Part 34 of a Series on Evaluation of Scientific PublicationsBernd Kowall, Susanne Stolpe, Wolfgang Galetzka, et al.
Entropy (Basel, Switzerland)|October 28, 2023
Distance-Metric Learning for Personalized Survival AnalysisWolfgang Galetzka, Bernd Kowall, Cynthia Jusi, et al.
BMC Neurology|December 12, 2019
Epidemiology and health care utilization of patients suffering from Huntington's disease in Germany: real world evidence based on German claims dataChristoph Ohlmeier, Kai-Uwe Saum, Wolfgang Galetzka, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|October 24, 2019
Comparison of Approaches to Select a Propensity Score Matched Control Group in the Absence of an Obvious Start of Follow Up for this Group: An Example Study on the Economic Impact of the DMP Bronchial AsthmaJosephine Jacob, Niklas Schmedt, Lennart Hickstein, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
Accuracy of a Smartphone-Based Artificial Intelligence Application for Classification of Melanomas, Melanocytic Nevi, and Seborrheic KeratosesJokubas Liutkus, Arturas Kriukas, Dominyka Stragyte, et al.
Dermatology and Therapy|July 24, 2022
Treatment Patterns and Healthcare Resource Utilization Among Patients with Atopic Dermatitis: A Retrospective Cohort Study Using German Health Claims DataMarie Schild, Valeria Weber, Diamant Thaçi, et al.
Pneumonia (Nathan Qld.)|March 25, 2023
Healthcare resource utilization and cost of pneumococcal disease in children in Germany, 2014-2019: a retrospective cohort studyTianyan Hu, Bélène Podmore, Rosemarie Barnett, et al.
BMC Infectious Diseases|September 28, 2022
Pneumococcal vaccination coverage in individuals (16-59 years) with a newly diagnosed risk condition in GermanyArijita Deb, Bélène Podmore, Rosemarie Barnett, et al.
Epidemiology and Infection|November 8, 2022
Clinical and economic burden of pneumococcal disease among individuals aged 16 years and older in GermanyArijita Deb, Bélène Podmore, Rosemarie Barnett, et al.
Plos One|May 2, 2020
Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims dataChristoph Ohlmeier, Holger Gothe, Judith Haas, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Deutsches Arzteblatt International|August 6, 2024
One Question, Many Results—Why Epidemiological Studies Yield Heterogeneous Findings. Part 34 of a Series on Evaluation of Scientific PublicationsBernd Kowall, Susanne Stolpe, Wolfgang Galetzka, et al.
Entropy (Basel, Switzerland)|October 28, 2023
Distance-Metric Learning for Personalized Survival AnalysisWolfgang Galetzka, Bernd Kowall, Cynthia Jusi, et al.
BMC Neurology|December 12, 2019
Epidemiology and health care utilization of patients suffering from Huntington's disease in Germany: real world evidence based on German claims dataChristoph Ohlmeier, Kai-Uwe Saum, Wolfgang Galetzka, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|October 24, 2019
Comparison of Approaches to Select a Propensity Score Matched Control Group in the Absence of an Obvious Start of Follow Up for this Group: An Example Study on the Economic Impact of the DMP Bronchial AsthmaJosephine Jacob, Niklas Schmedt, Lennart Hickstein, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
Accuracy of a Smartphone-Based Artificial Intelligence Application for Classification of Melanomas, Melanocytic Nevi, and Seborrheic KeratosesJokubas Liutkus, Arturas Kriukas, Dominyka Stragyte, et al.
Dermatology and Therapy|July 24, 2022
Treatment Patterns and Healthcare Resource Utilization Among Patients with Atopic Dermatitis: A Retrospective Cohort Study Using German Health Claims DataMarie Schild, Valeria Weber, Diamant Thaçi, et al.
Pneumonia (Nathan Qld.)|March 25, 2023
Healthcare resource utilization and cost of pneumococcal disease in children in Germany, 2014-2019: a retrospective cohort studyTianyan Hu, Bélène Podmore, Rosemarie Barnett, et al.
BMC Infectious Diseases|September 28, 2022
Pneumococcal vaccination coverage in individuals (16-59 years) with a newly diagnosed risk condition in GermanyArijita Deb, Bélène Podmore, Rosemarie Barnett, et al.
Epidemiology and Infection|November 8, 2022
Clinical and economic burden of pneumococcal disease among individuals aged 16 years and older in GermanyArijita Deb, Bélène Podmore, Rosemarie Barnett, et al.
Plos One|May 2, 2020
Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims dataChristoph Ohlmeier, Holger Gothe, Judith Haas, et al.
Pageof 3